UroGen Pharma Ltd. - COM (URGN)

Historical Portfolio Holders from Q2 2017 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
35.1M
Holdings value Q3 2024
$446M
Value change Q3 2024
-$58.5M
Grand Portfolio weight change Q3 2024
0%
Number of holders
127
Number of buys Q3 2024
71
Number of sells Q3 2024
-41
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 35.1M $446M -$58.5M $12.70 127
2024 Q2 38.2M $641M +$207M $16.78 115
2024 Q1 27.2M $407M +$84.9M $15.00 111
2023 Q4 21.4M $321M +$51.9M $15.00 104
2023 Q3 17.7M $248M +$65.7M $14.01 100
2023 Q2 13.2M $137M +$7.18M $10.35 85
2023 Q1 12.4M $115M -$4.45M $9.24 64
2022 Q4 13M $115M -$2.38M $8.87 63
2022 Q3 13.3M $111M -$982K $8.32 57
2022 Q2 13.4M $109M -$6.04M $8.19 60
2022 Q1 14.2M $124M +$1.87M $8.71 82
2021 Q4 14.7M $139M +$2.18M $9.51 71
2021 Q3 14.1M $237M +$1.24M $16.82 88
2021 Q2 14M $214M -$5.53M $15.27 78
2021 Q1 14.3M $278M -$4.2M $19.48 88
2020 Q4 14.5M $262M -$10.5M $18.02 81
2020 Q3 15M $289M +$6.24M $19.29 78
2020 Q2 14.7M $382M +$28.3M $26.12 83
2020 Q1 14M $249M -$10M $17.84 78
2019 Q4 14.2M $473M +$4.84M $33.37 85
2019 Q3 14.6M $347M -$26.2M $23.83 83
2019 Q2 14.7M $527M +$43.9M $35.94 84
2019 Q1 13.5M $497M +$143M $36.94 74
2018 Q4 9.59M $413M +$18.6M $43.06 64
2018 Q3 9.92M $469M +$14.7M $47.23 70
2018 Q2 9.6M $482M +$24.1M $49.76 60
2018 Q1 9.14M $454M +$119M $49.69 43
2017 Q4 5.74M $214M +$83.1M $37.21 40
2017 Q3 3.15M $98.4M +$1.69M $31.52 30
2017 Q2 4.72M $85.2M +$85.2M $18.06 21